Compare

Total Population
Adult Population
World Bank Income Group

HCV Model Status
HBV Model Status

Viremic Infections
Viremic Diagnosed
Annual Initiated Treatment Rate
Annual Liver-Related Deaths
Daily Liver-Related Deaths

HBsAg+ Infections
Total Diagnosed
Total on-Treatment Rate
Annual Liver-Related Deaths
Daily Liver-Related Deaths
Timely Birth Dose Vaccination
≥3 Dose Vaccination
HBIG
Antiviral Tx of Pregnant Women

HCV

Diagnosed (90% of Total Infections)
Treated (80% of eligible are treated)
Blood Safety
(100%)
Injection Safety
(90%)
Syringes/ PWID (300/PWID/YR)

HBV

Diagnosed (90% of total infections)
Treated (80% of eligible are treated)
Birth Dose Vaccination (90%)
Three Dose Vaccination (90%)
Blood Safety
(100%)
Injection Safety
(90%)
Syringes/ PWID
(300/PWID/YR)

HCV

All Goals
Diagnosed
(90%)
Treated
(80% of eligible)
Mortality
(65% reduction)
Incidence
(90% reduction)

HBV

All Goals
Diagnosed
(90%)
Treated
(80% of eligible)
Mortality
(65% reduction)
Prevalence among 5 y.o. (<0.1%)